Watch our webinar: Your Trial Post-Covid: Recovery Must Start Now

This webinar, hosted by Cromos Pharma with MKR Clinical Research Consultants (29 May 2020), explores strategic approaches to getting clinical trials back on track amid the ongoing COVID-19 pandemic. It also featured insights into optimal country choices to maximize enrolment as regions begin to reopen and lift pandemic restrictions.

“Using a scenario-based modelling approach the Cromos Pharma team has developed a comprehensive roadmap for sponsors to help them optimize recovery and get their trials back on track in the coming months,” said Dr Vlad Bogin, CEO, Cromos Pharma.

The roadmap to recovery developed by Cromos Pharma is based on an evidence-based approach and extensive risk-assessment. It aims to ensure that sponsors can get trials back up and running in the most effective manner possible.

If you would like further information on Cromos Pharma’s roadmap to recovery, please email bd@cromospharma.com.


Cromos Pharma proudly supports the Right2hope initiative, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us

OUR PUBLICATIONS